Mela Sciences, Inc

About MELA Sciences, Inc. MELA Sciences is a developer of innovative software-driven technology for the early detection of skin cancer. MELA is the developer of MelaFind® - the only device with FDA and CE Mark approvals that is designed to assist dermatologists in evaluating and diagnosing melanoma at its most curable and cost-effective stage. About MelaFind MelaFind is the first and only medical device with FDA Pre-Market Approval (PMA) for the U.S. and Conformité Européenne (CE) Marking certification for the European Union designed to assist dermatologists in the evaluation and diagnosis of melanoma at its most curable and cost-effective stage. The MelaFind system utilizes innovative software-driven technology and state-of-the-art 3-D optical imaging to non-invasively extract data up to 2.5 mm below the skin surface from patient’s pigmented ambiguous moles and objectively analyzes them with proprietary algorithms. MelaFind provides important additional perspective to physicians via 3-D spectral images and 100% objective data analysis to help them better understand the structural disorganization of a patient’s pigmented ambiguous moles (before cutting the skin) during the evaluation and diagnosis process for melanoma.